Mount Sinai’s Dr. Bruce Sands Receives Crohn’s and Colitis Foundation of America’s 2016 Lifetime Achievement Award

New York, NY
 – December 15, 2016 /Press Release/  –– 

Bruce E. Sands, MD, MS, Dr. Burrill B. Crohn Professor of Medicine, Chief of the Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, received the Henry D. Janowitz Lifetime Achievement Award at the 2016 Crohn’s & Colitis Foundation of America (CCFA) Advances in Inflammatory Bowel Diseases Clinical and Research Conference, held December 8-10 in Orlando, FL.

Dr. Sands was nominated by the medical and research community for his exceptional dedication to the field of IBD. For his entire professional career, Dr. Sands has focused his research and clinical care on IBD. He helped to launch the Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai and has been the principal investigator on a number of groundbreaking studies of new therapeutic agents for the treatment of IBD. He has published over 150 peer-reviewed articles on the topic of inflammatory bowel disease, including papers on etiology, diagnosis, prognosis, and treatment.

Dr. Sands previously served as the Chair of the CCFA’s Clinical Research Alliance, and on the National Scientific Advisory Committee. He is a past chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) and has also served as the Chair of the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association. Dr. Sands has been an Associate Editor for the journal Gastroenterology, and is on the Editorial Board of Inflammatory Bowel Diseases.

Before coming to Mount Sinai, Dr. Sands was on the faculty at Massachusetts General Hospital, where he founded and co-directed the MGH Inflammatory Bowel Disease Center and served as Acting Chief of the Gastrointestinal Unit. While in Boston, he served as Chair of the CCFA’s New England Chapter’s Medical Advisory Committee and was awarded Humanitarian of the Year in 2006.

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the “Honor Roll” of best hospitals in America, ranked No. 15 nationally in the 2016-2017 “Best Hospitals” issue of U.S. News & World Report.  The Mount Sinai Hospital is also ranked as one of the nation’s top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai’s Kravis Children’s Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."

For more information, visit or find Mount Sinai on Facebook, Twitter and YouTube.

# # #